Combination therapy with cyclosporin in rheumatoid arthritis

British Journal of Rheumatology

Volumn 35, Issue SUPPL. 2, 1996, Pages 19-23

  Yocum, D E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Combination therapy; Cyclosporin; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC AGENT; GOLD; HYDROXYCHLOROQUINE; METHOTREXATE; PENICILLAMINE; SALAZOSULFAPYRIDINE;

ARTICLE; COMBINATION CHEMOTHERAPY; DISEASE ACTIVITY; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFECTION; NEOPLASM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIDE EFFECT;

EID: 0029840001     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.suppl_2.19     Document Type: Article

References (34)

1. Lipsky PE. Rheumatoid arthritis. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's principles of internal medicine, 13th edn. New York: McGraw-Hill, 1994:1648-55.
2. Harris ED, Jr. Clinical features of rheumatoid arthritis. In: Kelley WN, Harris ED, Jr, Ruddy S, Sledge GB, eds. Textbook of rheumatology, 4th edn. Philadelphia: Saunders, 1993:874-911.
3. Gordon DA, Hastings DE. Rheumatoid arthritis clinical features. In: Klippel JH, Dieppe PA, eds. Rheumatology. St Louis: Mosby, 1994:3.4.1-3.4.14.
4. Pincus T, Callahan LF. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am 1993; 19:123-51.
5. Choy EHS, Scott DL. Prognostic markers in rheumatoid arthritis and classification of antirheumatic therapies: new perspectives. Drugs 1995;in press.
6. Amor B, Herson D, Cherot A, Delbarre F. Follow-up study of patients with rheumatoid arthritis over a period of more than 10 years (1966-1978): analysis of disease progression and treatment in 100 cases. Ann Med Int 1981;132:168-73.
7. Williams HJ, Willkens RF, Samuelson CO et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial. Arthritis Rheum 1985;28:721-30.
8. Bunch TW, O'Duffy JD, Tompkins RB, O'Fallon WM. Controlled trial of hydroxychloroquine and D-penicillamine singly and in combination in the treatment of rheumatoid arthritis. Arthritis Rheum 1984;27:267.
9. Tiliakos NA. Low-dose cytotoxic drug combination therapy in intractable rheumatoid arthritis: two years later. Arthritis Rheum 1986;29:S79.
10. Wahl SM, Wilder RL, Katona IM et al. Leukapheresis in rheumatoid arthritis: association of clinical improvement with reversal of anergy. Arthritis Rheum 1983;26:1076-84.
11. Csuka M, Carreara GF, McCarty DJ. Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine: a follow-up study. J Am Med Assoc 1986;255:2315-6.
12. Cash JM, Klippel JH. Second-line drug therapy for rheumatoid arthritis. N Eng J Med 1994;330:1368-75.
13. Pincus T, Marcum SB, Callahan LF. Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second-line drugs and prednisone. J Rheumatol 1992;19:1885-94.
14. Wolfe F, Hawley DJ, Cathey MA. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts. J Rheumatol 1990;17:994-1002.
15. Biro JA, Segal AM, MacKenzie AH, Mazanec DJ, Wilke WS. The combination of methotrexate and azathioprine for resistant rheumatoid arthritis. Arthritis Rheum 1987;30:S18.
16. Wilkens RF, Urowits MB, Stablei DM et al. Comparison of azathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1992;35:849-56.
17. Haagsma C, van Riel P, de Rooij DJ, van de Putte L. Combination therapy in RA: sulphasalazine and methotrexate. Arthritis Rheum 1993;36:S53 (abstract).
18. O'Dell J, Haire C, Erikson N et al. Triple DMARD therapy for rheumatoid arthritis: efficacy. Arthritis Rheum 1994;37:S295 (abstract).
19. Panayi GS. The immunopathogenesis of rheumatoid arthritis. Br J Rheumatol 1995;32(suppl. 1):4-14.
20. Kremer JM. Methotrexate (MTX) induces significant changes in IL-1, IL-2, IL-6 and IL-8 but not lymphocyte markers in patients (PTS) with rheumatoid arthritis (RA). Arthritis Rheum 1993;36(suppl.):S77 (abstract).
21. McKenna RM, Szturm K, Jefffery JR, Rush DN. Inhibition of cytokine production by cyclosporin A and G. Transplantation 1989;47:343-8.
22. Sigal NH, Dumont FJ. Pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 1992; 10:519-60.
23. Segal R, Mozes E, Yaron M, et al. The effects of methotrexate on the production and activity of interleukin-1. Arthritis Rheum 1989;32:370-7.
24. Førre Ø and The Norwegian Arthritis Study Group. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Arthritis Rheum 1994;37:1506-12.
25. Brahn E, Peacock DJ, Banquerigo ML. Suppression of collagen-induced arthritis by combination cyclosporin A and methotrexate therapy. Arthritis Rheum 1991; 34:1282-8.
26. Bensen W, Tugwell P, Roberts R et al. Combination therapy of cyclosporin with methotrexate and gold in rheumatoid arthritis (2 pilot studies). Arthritis Rheum 1994;37:S335 (abstract).
27. Tugwell P, Pincus T, Yocum DE, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
28. Stein CM, Pincus T, Brooks RH et al. Combination therapy with cyclosporine and methotrexate: results of a 24 week extension study subsequent to a 24 week double-blind study Arthritis Rheum 1994;37:S5252 (abstract).
29. Tugwell P, Bombardier C, Gent M et al. Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis. Lancet 1990;335:1051-5.
30. Landewé RBM, Miltenburg AMM, Breedveld FC, Daha MR, Dijkmans BAC. Cyclosporine and chloroquine synergistically inhibit the interferon gamma production by CD4-positive and CD8-positive synovial T cell clones derived from a patient with rheumatoid arthritis. Cyclosporine in RA 1964:111-23.
31. Landewé RBM, Miltenburg AMM, Verdonk MJA et al. Cyclosporine and chloroquine synergistically inhibit T cell proliferation by interference with IL-2 production and IL-2 responsiveness. Cyclosporine in RA 1964:125-46.
32. van den Borne BEEM, Landewé RBM, Goei The HS, Mattie H, Breedveld FC, Dijkmans BAC. Relative bioavailability of a new oral form of cyclosporin A in patients with rheumatoid arthritis. Br J Clin Pharmacol 1995;39:172-5.
33. + antibody treatment of patients with rheumatoid arthritis: 1. Effect on clinical and circulating T cells. J Autoimmunol 1989;2:627-42.
34. Cash JJ, Kavanaugh AF. Biologic intervention in rheumatoid arthritis. Rheum Dis Clin North Am 1995;21:797-816.